What is Vaxcyte, Inc.'s D&A?

Vaxcyte, Inc. (PCVX) reported D&A of $2.95M in Q1 2026.

How has Vaxcyte, Inc.'s D&A changed year-over-year?

Vaxcyte, Inc.'s D&A decreased by 0.3% year-over-year, from $2.96M to $2.95M.

What is the long-term trend for Vaxcyte, Inc.'s D&A?

Over 4 years (2021 to 2025), Vaxcyte, Inc.'s D&A has grown at a 73.7% compound annual growth rate (CAGR), from $1.8M to $16.4M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Vaxcyte, Inc. PCVX D&A

D&A at other companies

PfizerPFE

$1.61B-0.3%

ModernaMRNA

$59M+51.3%

Krystal Biotech, Inc.KRYS

$1.52M+7.9%

ImmunityBio, Inc.IBRX

$4.38M+14.4%

Vertex PharmaceuticalsVRTX

$55.9M+15.5%

Other financials

Income statement

See full

Operating income-$345.9M-91.3%

Net income-$320.6M-128%

EPS (diluted)-$2.30-121%

Balance sheet

See full

Cash & equivalents$262.3M-24.7%

Total debt$116.3M+33.5%

Total equity$3.0B-6.4%

Total assets$3.3B-0.9%

Cash flow

See full

Operating cash flow-$280.6M-68.8%

CapEx$2.1M-61.2%

Free cash flow-$282.7M-64.7%

Valuation

See full

Market cap$7.43B+72.0%

Enterprise value$7.28B+78.6%

Returns & leverage

See full

Return on equity-30.6%+37.9pp

Debt / equity0×0.0×

Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vaxcyte, Inc.'s D&A?: Vaxcyte, Inc. (PCVX) reported D&A of $2.95M in Q1 2026.
How has Vaxcyte, Inc.'s D&A changed year-over-year?: Vaxcyte, Inc.'s D&A decreased by 0.3% year-over-year, from $2.96M to $2.95M.
What is the long-term trend for Vaxcyte, Inc.'s D&A?: Over 4 years (2021 to 2025), Vaxcyte, Inc.'s D&A has grown at a 73.7% compound annual growth rate (CAGR), from $1.8M to $16.4M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.